SCHEMBL6803390

SCHEMBL6803390

CCCCCCCCCOCCCC(=O)O

nearest known ligand 0.67

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GPR84 Q9NQS5 7/20 0.67
PPARG P37231 7/20 0.67
PPARD Q03181 7/20 0.67
PPARA Q07869 7/20 0.67
HDAC11 Q96DB2 5/20 0.67
TSHR P16473 4/20 0.67
PTPN1 P18031 3/20 0.67
ALDH1A1 P00352 3/20 0.67
KMT2A Q03164 3/20 0.67
TLR2 O60603 2/20 0.67
TDP1 Q9NUW8 2/20 0.67
FABP4 P15090 2/20 0.67
MEN1 O00255 2/20 0.67
SLC22A6 Q4U2R8 1/20 0.67
SLC22A8 Q8TCC7 1/20 0.67
ESR1 P03372 1/20 0.67
ALOX15 P16050 1/20 0.67
PDE4A P27815 1/20 0.67
PDE3A Q14432 1/20 0.67
HSD17B10 Q99714 1/20 0.67

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7764672 1.00 GPR84 (0.67) GPR84PPARGPPARDPPARAHDAC11
SCHEMBL11228821 1.00 GPR84 (0.67) GPR84PPARGPPARDPPARAHDAC11
SCHEMBL28439052 1.00 GPR84 (0.67) GPR84PPARGPPARDPPARAHDAC11
SCHEMBL9455451 1.00 GPR84 (0.67) GPR84PPARGPPARDPPARAHDAC11
SCHEMBL9503519 1.00 GPR84 (0.67) GPR84PPARGPPARDPPARAHDAC11
SCHEMBL7496947 1.00 GPR84 (0.67) GPR84PPARGPPARDPPARAHDAC11
SCHEMBL9065811 1.00 GPR84 (0.67) GPR84PPARGPPARDPPARAHDAC11
SCHEMBL515623 1.00 GPR84 (0.67) GPR84PPARGPPARDPPARAHDAC11
SCHEMBL9066363 1.00 GPR84 (0.67) GPR84PPARGPPARDPPARAHDAC11
SCHEMBL17908855 0.98 GPR84 (0.64) GPR84PPARGPPARDPPARAHDAC11

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 16 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3441382-B1 OXA ACID COMPOUND MORESCO CORP (JP) 2023-08-30 EP disclosed
US-11021430-B2 Oxa acid compound MORESCO CORPORATION (JP) 2021-06-01 US disclosed
US-20190106373-A1 OXA ACID COMPOUND MORESCO CORPORATION (JP) 2019-04-11 US disclosed
US-20040063959-A1 Esters and amides as PLA2 inhibitors FUKAMI NAOKI (JP) 2004-04-01 US disclosed
US-20020169326-A1 Esters and amides as PLA2 inhibitors FUJISAWA PHARMACEUTICAL COMPANY, LTD. (JP) 2002-11-14 US disclosed
EP-0854863-B1 ESTERS AND AMIDES AS PLA2 INHIBITORS FUJISAWA PHARMACEUTICAL CO (JP) 2002-10-30 EP disclosed
US-20020019416-A1 ESTERS AND AMIDES AS PLA2 INHIBITORS FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 2002-02-14 US disclosed
US-6048989-A PARASITICIDES AND ANTIBROTOZOA AGENTS WASHINGTON UNIVERSITY (US) 2000-04-11 US disclosed
US-6025511-A A MYRISTIC ACID SELECTED ANALOGS FOR INHIBITING THE BIOSYNTHESIS OF THE GLYCOSYL PHOSPHATIDYLINOSITOL (GPI) ANCHOR OF THE PARASITE WASHINGTON UNIVERSITY (US) 2000-02-15 US disclosed
US-6001869-A CONTACTING THE PARASITE WITH 2-THIENYL-UNDECENOIC ACID/10-/ WASHINGTON UNIVERSITY (US) 1999-12-14 US disclosed
US-5998642-A Thienyl-containing fatty acid glycosyl phosphatidylinosital analogues used for inhibiting parasitic activity WASHINGTON UNIVERSITY (US) 1999-12-07 US disclosed
EP-0854863-A1 ESTERS AND AMIDES AS PLA2 INHIBITORS FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 1998-07-29 EP disclosed
US-5760259-A MYRISTIC ACID DERIVATIVES CAPABLE OF INHIBITING BIOSYNTHESIS OF PARASITE'S ANCHORING GROUP WASHINGTON UNIVERSITY (US) 1998-06-02 US disclosed
US-5747537-A Method of inhibiting parasitic activity WASHINGTON UNIVERSITY (US) 1998-05-05 US disclosed
WO-1997003951-A1 ESTERS AND AMIDES AS PLA2 INHIBITORS FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 1997-02-06 WO disclosed
US-5236955-A Anti-fungal agent WASHINGTON UNIVERSITY (US) 1993-08-17 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040063959-A1 Esters and amides as PLA2 inhibitors PLA2G4A, PLA2G2D, PLA2G4B GPR84 664/4885PPARG 301/4885PPARD 175/4885
US-20190106373-A1 OXA ACID COMPOUND OXA1L, ACOX1, ALOX12 GPR84 993/4885PPARG 1913/4885PPARD 1249/4885
US-20020019416-A1 ESTERS AND AMIDES AS PLA2 INHIBITORS PLA2G4A, PLA2G4B, PLA2G1B GPR84 618/4885PPARG 376/4885PPARD 256/4885
US-11021430-B2 Oxa acid compound OXA1L, ACOX1, OLA1 GPR84 1179/4885PPARG 2149/4885PPARD 1454/4885
US-20020169326-A1 Esters and amides as PLA2 inhibitors PLA2G4A, PLA2G2D, PLA2G4B GPR84 645/4885PPARG 297/4885PPARD 172/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.